Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001562180-25-004035

EVP & GENERAL COUNSEL sold 11,000 shares at an average $295.10 ($3,246,150)

  • EVP & GENERAL COUNSEL acquired 11,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MAHON PAUL A · EVP & GENERAL COUNSEL

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-15 Exercise or conversion : show line 1 in the form 10b5-1 +11,000 $117.76 $1,295,360 47,781 D
2025-05-15 Sale : show line 2 in the form 10b5-1 −2,139 $293.31 $627,399 45,642 D
2025-05-15 Sale : show line 3 in the form 10b5-1 −1,104 $293.96 $324,526 44,538 D
2025-05-15 Sale : show line 4 in the form 10b5-1 −5,004 $295.10 $1,476,680 39,534 D
2025-05-15 Sale : show line 5 in the form 10b5-1 −1,744 $296.41 $516,930 37,790 D
2025-05-15 Sale : show line 6 in the form 10b5-1 −800 $297.33 $237,866 36,990 D
2025-05-15 Sale : show line 7 in the form 10b5-1 −4 $299.00 $1,196 36,986 D
2025-05-15 Sale : show line 8 in the form 10b5-1 −203 $300.24 $60,948 36,783 D
2025-05-15 Sale : show line 9 in the form 10b5-1 −2 $302.02 $604 36,781 D
Open-market sales · 11,000 sh · avg $295.10 · $3,246,150

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-05-15 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −11,000 $117.76 2027-03-15 11,000 4,000 D
Loading xslF345X05/primarydocument.xml…